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Background: During the past decades, there has been a surge in prescribing opioids for 
pain related conditions, the “opioid epidemic”. It is critical for researchers and clinicians 
to explore other non-pharmacological approaches to manage pain instead of relying on 
opioid analgesics. Acupuncture could be an effective tool to modulate pain. 
Since 1999, studies on the effect of acupuncture on pressure pain threshold (PPT), at the 
University of Technology Sydney (UTS), have been conducted. The effects of the 
acupuncture to the acupoint LI 4 (Hegu) on PPT, the strength and quality of needling 
sensation (deqi) and the intensity of needling pain have been investigated by researchers 
from the UTS acupuncture group. However, the effects of another acupoint, Small 
Intestine 3 (SI 3 -Houxi) a commonly used acupoint for the treatment of various pain-
related conditions has not been explored for its effect on PPT and deqi. 
Aim: The primary aim of this study was to investigate the effects of needling the acupoint 
SI 3 in healthy people on: 
1. Regional PPT at ten sites (SI 11R, SI 11L, GV 4, GV 14, HT 7R, HT 7L, BL 60R, BL 
60L, GB 21R, GB 21L) following three different interventions - SI3m+, SI3m- and SL;  
2. The strength and quality of needling sensation (deqi) reported by subjects; and 
3. The intensity of pain associated with the intervention. 
Methods: Prior to commencing the study a systematic review was undertaken on the 
clinical use of acupoint SI 3 and PPT in acupuncture clinical studies. Following the 
reviews, this prospective study was designed as a randomised, double-blind, three-arm, 
and cross-over experimental study to investigate the effects of needling SI 3 on regional 
PPT, deqi and needling pain.  
Results: For SI3m+ and SI3m- interventions, the post intervention mean % PPT scores 
were significantly elevated compared with SL (p < 0.001). SI3m+ statistically 
significantly elevated PPT% comparing to SI3m- (p < 0.001). The mean needle sensation 
and pain scores were similar for the two needling interventions, but both increased when 
comparing to SL. The subjects’ anxiety and tension levels were not significantly different 
across the interventions.  
Conclusions: Both intervention and site of needling were found to be important 




findings that support the belief that obtaining deqi during acupuncture is necessary for 
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